Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Yi Hsieh

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Sensors (Basel, Switzerland)|July 28, 2022
Developing a Method to Estimate the Downstream Metabolite Signals from Hyperpolarized [1-<sup>13</sup>C]PyruvateChing-Yi Hsieh, Cheng-Hsuan Sung, Yi-Liang Eric Shen, et al.
Magnetic Resonance in Medicine|November 1, 2015
A quantitative study of susceptibility and additional frequency shift of three common materials in MRIHe Xie, Yu-Chung N Cheng, Paul Kokeny, et al.
Korean Journal of Radiology|April 30, 2024
Hyperpolarized Carbon-13 Magnetic Resonance Imaging: Technical Considerations and Clinical ApplicationsYing-Chieh Lai, Ching-Yi Hsieh, Yu-Hsiang Juan, et al.
Cancer Biology & Therapy|January 17, 2004
The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformationHong He, Yumiko Hirokawa, Aviv Gazit, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Magnetic Resonance Spectroscopy for Risk Stratification of Sonographically Indeterminate Ovarian Neoplasms: Preliminary StudyYenpo Lin, Ching-Yi Hsieh, Yen-Ling Huang, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Comparing Magnetic Resonance Fingerprinting (MRF) and the MAGiC Sequence for Simultaneous T1 and T2 Quantitative Measurements in the Female Pelvis: A Prospective StudyBo-Syuan Huang, Ching-Yi Hsieh, Wen-Yen Chai, et al.
Metabolites|August 26, 2021
Monitoring Early Glycolytic Flux Alterations Following Radiotherapy in Cancer and Immune Cells: Hyperpolarized Carbon-13 Magnetic Resonance Imaging StudyYing-Chieh Lai, Ching-Yi Hsieh, Kuan-Ying Lu, et al.
European Radiology Experimental|April 9, 2024
Hyperpolarized [1-<sup>13</sup>C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancerGigin Lin, Ching-Yi Hsieh, Ying-Chieh Lai, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 24, 2024
Endometrial cancer risk stratification using MRI radiomics: corroborating with choline metabolismYenpo Lin, Ren-Chin Wu, Yu-Chun Lin, et al.
Magnetic Resonance in Medicine|June 16, 2025
Consensus recommendations for hyperpolarized [1-<sup>13</sup>C]pyruvate MRI multi-center human studiesShonit Punwani, Peder E Z Larson, Christoffer Laustsen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Sensors (Basel, Switzerland)|July 28, 2022
Developing a Method to Estimate the Downstream Metabolite Signals from Hyperpolarized [1-<sup>13</sup>C]PyruvateChing-Yi Hsieh, Cheng-Hsuan Sung, Yi-Liang Eric Shen, et al.
Magnetic Resonance in Medicine|November 1, 2015
A quantitative study of susceptibility and additional frequency shift of three common materials in MRIHe Xie, Yu-Chung N Cheng, Paul Kokeny, et al.
Korean Journal of Radiology|April 30, 2024
Hyperpolarized Carbon-13 Magnetic Resonance Imaging: Technical Considerations and Clinical ApplicationsYing-Chieh Lai, Ching-Yi Hsieh, Yu-Hsiang Juan, et al.
Cancer Biology & Therapy|January 17, 2004
The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformationHong He, Yumiko Hirokawa, Aviv Gazit, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
Magnetic Resonance Spectroscopy for Risk Stratification of Sonographically Indeterminate Ovarian Neoplasms: Preliminary StudyYenpo Lin, Ching-Yi Hsieh, Yen-Ling Huang, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Comparing Magnetic Resonance Fingerprinting (MRF) and the MAGiC Sequence for Simultaneous T1 and T2 Quantitative Measurements in the Female Pelvis: A Prospective StudyBo-Syuan Huang, Ching-Yi Hsieh, Wen-Yen Chai, et al.
Metabolites|August 26, 2021
Monitoring Early Glycolytic Flux Alterations Following Radiotherapy in Cancer and Immune Cells: Hyperpolarized Carbon-13 Magnetic Resonance Imaging StudyYing-Chieh Lai, Ching-Yi Hsieh, Kuan-Ying Lu, et al.
European Radiology Experimental|April 9, 2024
Hyperpolarized [1-<sup>13</sup>C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancerGigin Lin, Ching-Yi Hsieh, Ying-Chieh Lai, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 24, 2024
Endometrial cancer risk stratification using MRI radiomics: corroborating with choline metabolismYenpo Lin, Ren-Chin Wu, Yu-Chun Lin, et al.
Magnetic Resonance in Medicine|June 16, 2025
Consensus recommendations for hyperpolarized [1-<sup>13</sup>C]pyruvate MRI multi-center human studiesShonit Punwani, Peder E Z Larson, Christoffer Laustsen, et al.
Pageof 3